Glaxosmithkline | صافي الدخل



Net Income تغيير تاريخ
AbbVie USD 1.29B 1.31B 2025-03
Amgen USD 1.73B 1.1B 2025-03
AstraZeneca USD 2.92B 1.42B 2025-03
Aurora Cannabis CAD 31.67M 43.71M 2024-12
Bausch Health Companies USD -58000000 151M 2025-03
Bristol-Myers Squibb USD 2.46B 2.38B 2025-03
Canopy Growth CAD -121896000 6.4M 2024-12
Corcept Therapeutics USD 20.55M 10.2M 2025-03
Drreddys Laboratories INR 14.13B 1.58B 2024-12
Eli Lilly USD 2.76B 1.65B 2025-03
GlaxoSmithKline GBP 1.62B 1.21B 2025-03
Glaxosmithkline GBP 414M 472M 2024-12
Indivior 48M 11M 2025-03
J&J USD 11B 7.57B 2025-03
Merck USD 5.08B 1.34B 2025-03
Novartis USD 2.82B 371M 2024-12
Pacira USD 4.81M 11.23M 2025-03
Perrigo USD -6400000 38.1M 2025-03
Pfizer USD 2.97B 2.56B 2025-03
Prestige Brands USD 50.13M 10.9M 2025-03
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 1.87B 1.37B 2025-03
Supernus Pharmaceuticals USD 15.33M 23.17M 2024-12
Takeda JPY -103155000000 126.94B 2025-03
Teva Pharmaceutical Industries USD 214M 431M 2025-03
Zoetis USD 631M 50M 2025-03



Glaxosmithkline صافي الدخل - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.